DB
DRUG

Dmitry Balyasny’s Bright Minds Biosciences DRUG Stock Holding History

Dmitry Balyasny’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.2M Buy
345,053
+47,895
+16% +$3.76M 0.03% 630
2026
Q1 		$21.7M Buy
297,158
+71,746
+32% +$5.78M 0.03% 657
2025
Q4 		$17.6M Buy
225,412
+38,490
+21% +$2.57M 0.02% 781
2025
Q3 		$11.3M Buy
+186,922
New +$7.26M 0.01% 988

Other funds holding DRUG

JT
Jupiter Topco New York $245B AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Dmitry Balyasny's DRUG Position: Q2 2026 in Review

Dmitry Balyasny increased its Bright Minds Biosciences (DRUG) stake by 16% in Q2 2026, buying an estimated $3.76M and bringing the position to 345,053 shares worth $24.2M. The position accounts for 0.03% of the portfolio, ranked #630.

Dmitry Balyasny first reported a position in DRUG in Q3 2025 and has held it in 4 quarters since. 99 funds tracked by Wall St. Rank hold DRUG as of Q2 2026.

  • Dmitry Balyasny held 345,053 shares of Bright Minds Biosciences worth $24.2M as of Q2 2026.
  • Dmitry Balyasny bought 47,895 Bright Minds Biosciences shares in Q2 2026, an estimated $3.76M.
  • Bright Minds Biosciences made up 0.03% of Dmitry Balyasny's portfolio in Q2 2026, its #630 holding.
  • Dmitry Balyasny first reported a position in Bright Minds Biosciences in Q3 2025 and has held it in 4 quarters since.
  • 99 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.